Lamisil Dermgel (Terbinafine)

Terbinafine blocks the fungal enzyme squalene epoxidase, preventing the synthesis of ergosterol, an essential component of fungal cell membranes. The resulting buildup of squalene and loss of ergosterol compromise membrane integrity, leading to fungal cell death.

The prescribed amount of Lamisil Dermgel is determined by the treating clinician based on the infection type, location and severity. Patients should follow the healthcare professional’s instructions for the frequency and duration of application.

Safety data for topical terbinafine in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Lamisil Dermgel.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with azole‑based topical agents, terbinafine has a different mechanism of action and often achieves faster clinical resolution of dermatophyte infections. It is generally well‑tolerated, but choice of therapy should consider the specific pathogen, infection site and patient factors.

Lamisil Dermgel should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight to maintain product stability.

The gel is applied thinly to the affected skin area once or twice daily, as directed by a healthcare professional. The skin should be clean and dry before application, and hands should be washed after use to avoid accidental contact with other surfaces.

Although rare, serious adverse reactions can include severe allergic responses such as angioedema, anaphylaxis, or Stevens‑Johnson syndrome. Patients should discontinue use and seek immediate medical attention if they experience swelling, blistering, widespread rash or any signs of systemic allergy.

Individuals with a known hypersensitivity to terbinafine, other allylamines, or any component of the gel formulation should avoid its use. It is also contraindicated on extensive broken skin or in patients where a healthcare professional advises against topical antifungal therapy.